Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterLetter

Incidence of Total Hip and Knee Replacement in UK Patients with Ankylosing Spondylitis

SAMUEL HAWLEY, SARAH SACKS, PAUL BOWNESS and DANIEL PRIETO-ALHAMBRA
The Journal of Rheumatology September 2018, 45 (9) 1334-1336; DOI: https://doi.org/10.3899/jrheum.171387
SAMUEL HAWLEY
Research Statistician, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SARAH SACKS
Rheumatology Registrar, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAUL BOWNESS
Professor of Experimental Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DANIEL PRIETO-ALHAMBRA
Associate Professor of Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, and Grup de Recerca en Malalties Prevalents de l’Aparell Locomotor (GREMPAL) Research Group, IDIAP Jordi Gol Primary Care Research Institute, and CIBERFES, Universitat Autònoma de Barcelona, and Instituto de Salud Carlos III Universitat Autònoma de Barcelona, Instituto de Salud Carlos III, Barcelona, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: daniel.prietoalhambra@ndorms.ox.ac.uk
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

To the Editor:

Ankylosing spondylitis (AS) is a chronic inflammatory disease of the axial skeleton manifested by back pain and progressive stiffness. However, it is not uncommon for peripheral joints to be involved; the underlying histopathology of which is characterized by subchondral bone inflammation that can result in joint erosion and eventual destruction. There have been emerging data on the need for joint replacement surgery among patients with AS1,2,3, although these data have mainly originated from cohorts of patients under hospital care or registry data and therefore may be more selective of severe disease. Our aim here was to better understand the need for joint replacement surgery in the overall AS population in the United Kingdom by using National Health Service (NHS) primary care electronic medical records to determine the incidence of total hip replacement (THR) and total knee replacement (TKR) following diagnosis of AS.

We identified patients in the Clinical Practice Research Datalink (CPRD) with a first diagnosis of AS within the United Kingdom between January 1, 1995, and March 31, 2014. We excluded patients with a diagnosis of > 1 type of inflammatory arthritis. CPRD is a primary care database that includes computerized, anonymized general practitioner records for over 6 million current UK patients. First occurrence of THR or TKR after AS diagnosis was identified using previously published/validated READ code lists4. Patients were followed from AS diagnosis until the date of first recorded THR and/or TKR (analyzed separately) or censoring [death, transference out of CPRD, or end of study period (April 2014)]. Unadjusted incidence rates were calculated per 1000 person-years (PY) and stratified by sex, age category, indices of multiple deprivation (IMD), region, and availability of anti–tumor necrosis factor (TNF) therapy for patients with AS (i.e., before vs after publication of National Institute for Health and Care Excellence TA143, guidance that first recommended the use of TNF-α inhibitors in AS, in 2008). The CPRD independent scientific advisory committee reviewed and approved the study (protocol number: 14_126RAR). Further ethical approval was not required because this study used only pseudo-anonymized routinely collected health data.

We identified 9766 patients with incident AS. The mean age at diagnosis was 50.0 years (SD 16.8), and 62.1% were female. In total, 173 THR and 139 TKR occurred at an incidence rate of 2.65/1000 PY (95% CI 2.29–3.08) and 2.13/1000 PY (95% CI 1.80–2.51), respectively. Incidence rates stratified by demographic variables are shown in Table 1. Joint replacement rates rose with increasing age but did not change according to sex, geographic region, availability of TNF-α inhibitors, or IMD, although there was a trend toward lower rates among those most deprived. Overall 5-year cumulative percentage probability (using the Kaplan-Meier method) of THR and TKR were 1.28% (95% CI 1.05–1.55) and 1.04% (0.83–1.30), respectively. At 10 years these rates were 2.55% (2.14–3.02) and 1.79% (1.47–2.19; Figure 1 and Figure 2).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Kaplan-Meier failure function: percentage probability of total hip replacement following ankylosing spondylitis diagnosis (first 10 years).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Kaplan-Meier estimate: percentage probability of total knee replacement following ankylosing spondylitis diagnosis (first 10 years).

View this table:
  • View inline
  • View popup
Table 1.

Incidence rates (per 1000 person-yrs) of total hip replacement (THR) and total knee replacement (TKR).

For the general UK population (CPRD), previously reported estimates of 10-year risk (aged 50) of undergoing THR were 1.1% (95% CI 0.8–1.4) and 0.8% (95% CI 0.5–1.0) for women and men, respectively5. Estimates for TKR were 1.1% (95% CI 0.8–1.4) and 0.6% (95% CI 0.4–0.9) for women and men, respectively. Our data, in conjunction with these previous estimates, tend to suggest a greater need for both THR and TKR in patients with AS compared to the general population, especially for THR.

However, comparing our estimates to those of previous AS studies is difficult because of differences in study designs and data used. Interestingly, we identified more AS cases in women than in men. This finding is not without support from population and magnetic resonance imaging–based studies that show nearly comparable sex ratios and that suggest that male sex may be a marker for more severe radiographic disease rather than for the disease itself6,7,8.

In contrast to the findings of Nystad, et al2, we did not detect lower THR rates following the introduction of TNF-α inhibitors in AS. Our findings on TKR also contrast with UK studies on rheumatoid arthritis4,9. It may be that we had an inadequate followup period to detect a change following introduction of TNF-α inhibitors in 2008. Further, the relatively stable rates of arthroplasty should be interpreted in conjunction with other reports of a general increase in such surgeries for the general population10.

We acknowledge our lack of individual validation of each patient diagnosis (AS) and surgery (THR/TKR), although the accuracy of THR/TKR procedures as reported in CPRD has previously been demonstrated4. We also recognize that AS-specific clinical variables (e.g., AS severity or presence of entheseal disease) and certain data on demographic characteristics were unknown/incomplete.

A key strength, however, is the use of a large primary care cohort using real-world UK data that includes potentially anyone seen in the NHS with a diagnosis of AS. We show here that the 10-year risks of THR and TKR are 2.6% and 1.8%, respectively, suggesting a greater need for THR and to a lesser extent, TKR in patients with AS compared to the general population. These findings will be helpful for healthcare economic planning for patients with AS.

Footnotes

  • Work described in this letter was funded by the Oxford National Institute for Health Research Biomedical Research Unit (SH, PB, DPA) and Biomedical Research Centre (PB). DPA is funded by a National Institute for Health Research Clinician Scientist award (CS-2013-13-012). DPA’s research group has received unrestricted research grants from Amgen, Servier Laboratoires, and UCB Pharma.

REFERENCES

  1. 1.↵
    1. Vander Cruyssen B,
    2. Munoz-Gomariz E,
    3. Font P,
    4. Mulero J,
    5. de Vlam K,
    6. Boonen A,
    7. et al.
    Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology 2010;49:73–81.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Nystad TW,
    2. Furnes O,
    3. Havelin LI,
    4. Skredderstuen AK,
    5. Lie SA,
    6. Fevang BT
    . Hip replacement surgery in patients with ankylosing spondylitis. Ann Rheum Dis 2014;73:1194–7.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Jeong H,
    2. Eun YH,
    3. Kim IY,
    4. Kim H,
    5. Lee J,
    6. Koh EM,
    7. et al.
    Characteristics of hip involvement in patients with ankylosing spondylitis in Korea. Korean J Intern Med 2017;32:158–64.
    OpenUrl
  4. 4.↵
    1. Hawley S,
    2. Cordtz R,
    3. Lene D,
    4. Edwards CJ,
    5. Arden NK,
    6. Delmestri A,
    7. et al.
    Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis. Semin Arthritis Rheum 2018;47:605–10.
    OpenUrl
  5. 5.↵
    1. Culliford DJ,
    2. Maskell J,
    3. Kiran A,
    4. Judge A,
    5. Javaid MK,
    6. Cooper C,
    7. et al.
    The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database. Osteoarthritis Cartilage 2012;20:519–24.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Webers C,
    2. Essers I,
    3. Ramiro S,
    4. Stolwijk C,
    5. Landewe R,
    6. van der Heijde D,
    7. et al.
    Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study. Rheumatology 2016;55:419–28.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Lee W,
    2. Reveille JD,
    3. Davis JC Jr,
    4. Learch TJ,
    5. Ward MM,
    6. Weisman MH
    . Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis 2007;66:633–8.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Hung YM,
    2. Chang WP,
    3. Wei JC,
    4. Chou P,
    5. Wang PY
    . Midlife ankylosing spondylitis increases the risk of cardiovascular diseases in males 5 years later: a national population-based study. Medicine 2016;95:e3596.
    OpenUrl
  9. 9.↵
    1. Harty L,
    2. O’Toole G,
    3. FitzGerald O
    . Profound reduction in hospital admissions and musculoskeletal surgical procedures for rheumatoid arthritis with concurrent changes in clinical practice (1995–2010). Rheumatology 2015;54:666–71.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. National Joint Registry for England and Wales
    . 12th Annual Report. 2015. [Internet. Accessed May 2, 2018.] Available from: www.njrcentre.org.uk/njrcentre/NJR12thAnnualReport/tabid/392/Default.aspx
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 45, Issue 9
1 Sep 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Incidence of Total Hip and Knee Replacement in UK Patients with Ankylosing Spondylitis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Incidence of Total Hip and Knee Replacement in UK Patients with Ankylosing Spondylitis
SAMUEL HAWLEY, SARAH SACKS, PAUL BOWNESS, DANIEL PRIETO-ALHAMBRA
The Journal of Rheumatology Sep 2018, 45 (9) 1334-1336; DOI: 10.3899/jrheum.171387

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Incidence of Total Hip and Knee Replacement in UK Patients with Ankylosing Spondylitis
SAMUEL HAWLEY, SARAH SACKS, PAUL BOWNESS, DANIEL PRIETO-ALHAMBRA
The Journal of Rheumatology Sep 2018, 45 (9) 1334-1336; DOI: 10.3899/jrheum.171387
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • To the Editor:
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Does the BNT162b2 Vaccine Trigger Antimelanoma Differentiation-Associated Gene 5 Antibody–Positive Interstitial Lung Disease?
  • Duration of Steroid Therapy and Temporal Artery Biopsy Positivity in Giant Cell Arteritis: A Retrospective Cohort Study
  • Desk Rejections: Not Without Due Deliberation
Show more Letters

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire